- Yonsei Criteria, a Potential Linkage to Intratumoral Foxp3âº/CD8⺠Ratio for the Prediction of Oncologic Outcomes in Resected Left-Sided Pancreatic Cancer
-
Hwang HK, Lee SH, Kim HI, Kim SH, Choi J, Kang CM, Lee WJ
- KMID: 2471914
- Yonsei Med J.
- 2020 Apr;61(4):291-300.
- doi: 10.3349/ymj.2020.61.4.291
PURPOSE: This study sought to investigate associations among Yonsei criteria (tumor confined to the pancreas, intact fascia layer between the distal pancreas and the left adrenal gland and kidney, and... -
- CITED
-
- Close
- SHARE
-
- Close
- A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer
-
Park J, Eoh KJ, Nam EJ, Kim S, Kim SW, Kim YT, Lee JY
- KMID: 2471913
- Yonsei Med J.
- 2020 Apr;61(4):284-290.
- doi: 10.3349/ymj.2020.61.4.284
PURPOSE: We evaluated whether adding bevacizumab to current platinum-based chemotherapy could improve clinical outcomes without affecting safety. MATERIALS AND METHODS: We retrospectively reviewed medical records of patients with pathologically confirmed ovarian... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Androgen Deprivation Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Docetaxel-Based Chemotherapy
-
Min K, Chung JW, Ha YS, Lee JN, Kim BS, Kim HT, Kim TH, Yoo ES, Kwon TG, Chung SK, Tanaka M, Egawa S, Kimura T, Choi SH
- KMID: 2471829
- World J Mens Health.
- 2020 Apr;38(2):226-235.
- doi: 10.5534/wjmh.190029
PURPOSE: The purpose of this study was to determine the comparative effectiveness of androgen deprivation therapy (ADT) combined with docetaxel (DTX)-based chemotherapy in Korean and Japanese castration-resistant prostate cancer (CRPC)... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimized Image-Based Surrogate Endpoints in Targeted Therapies for Glioblastoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
-
Suh CH, Kim HS, Jung SC, Choi CG, Kim SJ, Kim KW
- KMID: 2471813
- Korean J Radiol.
- 2020 Apr;21(4):471-482.
- doi: 10.3348/kjr.2019.0839
OBJECTIVE: We aimed to determine the optimized image-based surrogate endpoints (IBSEs) in targeted therapies for glioblastoma through a systematic review and meta-analysis of phase III randomized controlled trials (RCTs). MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience
-
Wu A, Graf SA, Burwick N, Grim JE, Dong ZM, Richard RE, Chauncey T
- KMID: 2472009
- Blood Res.
- 2020 Mar;55(1):57-61.
- doi: 10.5045/br.2020.55.1.57
BACKGROUND: Autologous stem cell transplantation (autoSCT) can extend remission of mantle cell lymphoma (MCL), but the management of subsequent relapse is challenging. METHODS: We examined consecutive patients with MCL who underwent... -
- CITED
-
- Close
- SHARE
-
- Close
- Similar transplant outcomes between haploidentical and unrelated donors after reduced-intensity conditioning with busulfan, fludarabine, and anti-thymocyte globulin in patients with acute leukemia or myelodysplastic syndrome
-
Choi M, Heo JY, Shin DY, Lee JY, Koh Y, Hong J, Kim I, Yoon SS, Lee JO, Bang SM
- KMID: 2472005
- Blood Res.
- 2020 Mar;55(1):27-34.
- doi: 10.5045/br.2020.55.1.27
BACKGROUND: Although T-cell-replete hematopoietic cell transplantation (HCT) from haploidentical donors (HIDs) using anti-thymocyte globulin (ATG) has shown promising outcomes, previous studies often adopted heterogenous graft sources and conditioning. METHODS: We retrospectively... -
- CITED
-
- Close
- SHARE
-
- Close
- BRCA1-associated protein 1 expression and prognostic role in prostate adenocarcinoma
-
Oh H, Lee YJ, Kang SG, Ahn B, Kim E, Chae YS, Lee Y, Lee JH, Kim CH
- KMID: 2471072
- Investig Clin Urol.
- 2020 Mar;61(2):166-172.
- doi: 10.4111/icu.2020.61.2.166
PURPOSE: As prostate cancer (PCa) is the second most commonly diagnosed cancer worldwide, finding novel markers for prognosis is crucial. BRCA1-associated protein 1 (BAP-1), a nuclear-localized deubiquitinating enzyme, has been... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival prognoses of Heng intermediate-risk patients with metastatic renal cell carcinoma treated with immunotherapy or targeted therapy: A real-world, single-center retrospective study
-
Kim SH, Lee DE, Joung JY, Seo HK, Lee KH, Chung J
- KMID: 2471070
- Investig Clin Urol.
- 2020 Mar;61(2):146-157.
- doi: 10.4111/icu.2020.61.2.146
PURPOSE: This study aimed to compare progression-free survival (PFS), overall survival (OS), and cancer-specific survival (CSS) in Heng intermediate-risk patients with metastatic renal cell carcinoma (mRCC) treated with first-line immunotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
-
Kim YN, Lee YJ, Lee JY, Nam EJ, Kim SW, Kim S, Kim YT
- KMID: 2470873
- J Gynecol Oncol.
- 2020 Mar;31(2):e23.
- doi: 10.3802/jgo.2020.31.e23
OBJECTIVE: To compare the efficacy and toxicity of dose-dense weekly paclitaxel and 3-weekly carboplatin (ddPC) as neoadjuvant chemotherapy (NAC) with the standard 3-weekly regimen. METHODS: A retrospective study of patients diagnosed... -
- CITED
-
- Close
- SHARE
-
- Close
- Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma
-
Iijima M, Okonogi N, Nakajima N, Morokoshi , Kanda H, Yamada T, Kobayashi , Banno K, Wakatsuki , Yamada S, Kamada T, Aoki D, Hasegawa S
- KMID: 2470870
- J Gynecol Oncol.
- 2020 Mar;31(2):e19.
- doi: 10.3802/jgo.2020.31.e19
OBJECTIVE: Programmed cell death-ligand 1 (PD-L1) is expressed in tumor cells and has been shown to predict clinical outcomes of several types of malignancies. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Completion hysterectomy after chemoradiotherapy for locally advanced adeno-type cervical carcinoma: updated survival outcomes and experience in post radiation surgery
-
Yang J, Yang J, Cao D, Shen K, Ma J, Zhang F
- KMID: 2470869
- J Gynecol Oncol.
- 2020 Mar;31(2):e16.
- doi: 10.3802/jgo.2020.31.e16
OBJECTIVE: To compare patient survival outcomes between completion hysterectomy and conventional surveillance in locally advanced adenocarcinoma of the cervix after concurrent chemoradiotherapy (CCRT). METHODS: Patients with adenocarcinoma of the cervix after... -
- CITED
-
- Close
- SHARE
-
- Close
- Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study
-
Park SJ, Kim J, Kim HS, Lee JW, Chang HK, Lee KH, Kim DY, Kim S, Chang SJ, Han SS, Park SY, Shim SH
- KMID: 2470868
- J Gynecol Oncol.
- 2020 Mar;31(2):e15.
- doi: 10.3802/jgo.2020.31.e15
OBJECTIVE: To evaluate the effectiveness and safety of the combination of pegylated liposomal doxorubicin with carboplatin (CD) compared with those of carboplatin and paclitaxel (CP) for platinum-sensitive recurrent ovarian, fallopian,... -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma
-
Lee SJ, Kim JH, Kim SY, Won HJ, Shin YM, Kim PN
- KMID: 2470755
- Korean J Radiol.
- 2020 Mar;21(3):316-324.
- doi: 10.3348/kjr.2019.0647
OBJECTIVE: To retrospectively evaluate the safety and efficacy of percutaneous radiofrequency ablation (RFA) in patients with metachronous hepatic metastases arising from pancreatic adenocarcinoma who had previously received curative surgery. MATERIALS AND... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiac Magnetic Resonance Feature Tracking in Aortic Stenosis: Exploration of Strain Parameters and Prognostic Value in Asymptomatic Patients with Preserved Ejection Fraction
-
Kim MY, Park EA, Lee W, Lee SP
- KMID: 2470750
- Korean J Radiol.
- 2020 Mar;21(3):268-279.
- doi: 10.3348/kjr.2019.0441
OBJECTIVE: To determine the most valuable cardiac magnetic resonance feature tracking (CMR-FT) parameters for evaluating aortic stenosis (AS) and determine whether they can predict the prognosis in asymptomatic AS patients... -
- CITED
-
- Close
- SHARE
-
- Close
- BRCA1/BRCA2 Pathogenic Variant Breast Cancer: Treatment and Prevention Strategies
-
Lee A, Moon BI, Kim TH
- KMID: 2460908
- Ann Lab Med.
- 2020 Mar;40(2):114-121.
- doi: 10.3343/alm.2020.40.2.114
Hereditary breast cancer is known for its strong tendency of inheritance. Most hereditary breast cancers are related to BRCA1/BRCA2 pathogenic variants. The lifelong risk of breast cancer in pathogenic BRCA1... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term outcome of intraoperative radiofrequency ablation for hepatocellular carcinoma and its efficacy as a primary treatment
-
Kwon J, Chun KS, Song IS, Kim SH, Han S
- KMID: 2471185
- Ann Hepatobiliary Pancreat Surg.
- 2020 Feb;24(1):24-32.
- doi: 10.14701/ahbps.2020.24.1.24
BACKGROUNDS/AIMS: We conducted this study to identify long-term outcomes following intraoperative radiofrequency ablation (IO-RFA) for hepatocellular carcinoma (HCC) and to reveal independent prognostic factors for survival. METHODS: From December 1998 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Primary hepatic neuroendocrine tumours of liver- a rarity: Single centre analysis of 13 patients
-
Parray A, Patkar S, Goel M
- KMID: 2471184
- Ann Hepatobiliary Pancreat Surg.
- 2020 Feb;24(1):17-23.
- doi: 10.14701/ahbps.2020.24.1.17
BACKGROUNDS/AIMS: Primary hepatic neuroendocrine tumours (PHNETs) are a rarity and this rarity imparts management complexities. METHODS: A retrospective analysis of prospectively maintained liver database from 2009 to 2018 was performed and... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer
-
Lei C, Yang C, Xia B, Ji F, Zhang Y, Gao H, Xiong Q, Lin Y, Zhuang X, Zhang L, Zhu T, Cheng M, Yang M, Wang K
- KMID: 2470881
- J Breast Cancer.
- 2020 Feb;23(1):47-58.
- doi: 10.4048/jbc.2020.23.e11
PURPOSE: Tau is a microtubule-associated protein that can be found in both normal and abnormal breast cells. Whether the expression of Tau protein can predict the response to neoadjuvant chemotherapy... -
- CITED
-
- Close
- SHARE
-
- Close
- Downregulation of N-myc and STAT Interactor Protein Predicts Aggressive Tumor Behavior and Poor Prognosis in Invasive Ductal Carcinoma
-
Choi JE, Hyun CL, Jin MS, Lee KM, Moon JH, Ryu HS
- KMID: 2470880
- J Breast Cancer.
- 2020 Feb;23(1):36-46.
- doi: 10.4048/jbc.2020.23.e12
PURPOSE: We investigated the expression of the N-myc and STAT interactor (NMI) protein in invasive ductal carcinoma tissue and estimated its clinicopathologic significance as a prognostic factor. The expression levels... -
- CITED
-
- Close
- SHARE
-
- Close
- Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status
-
Choi J, Park CS, Seong MK, Seol H, Kim JS, Park IC, Noh WC, Kim HA
- KMID: 2470878
- J Breast Cancer.
- 2020 Feb;23(1):10-19.
- doi: 10.4048/jbc.2020.23.e5
PURPOSE: Phosphorylated ribosomal S6 kinase 1 (pS6K1) is a major downstream regulator of the mammalian target of rapamycin (mTOR) pathway. Recent studies have addressed the role of S6K1 in adipogenesis.... -
- CITED
-
- Close
- SHARE
-
- Close
